781 related articles for article (PubMed ID: 36069224)
41. [Corrigendum] Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer.
Song H; Dong M; Zhou J; Sheng W; Li X; Gao W
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36069219
[TBL] [Abstract][Full Text] [Related]
42. [Corrigendum] Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells
Xiong Z; Lü MH; Fan YH; Cao YL; Hu CJ; Wu YY; Wang SM; Luo G; Fang DC; Li C; Yang SM
Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35088885
[TBL] [Abstract][Full Text] [Related]
43. [Corrigendum] CCL22 and IL‑37 inhibit the proliferation and epithelial‑mesenchymal transition process of NSCLC A549 cells.
Chen YH; Zhou BY; Wu XJ; Xu JF; Zhang JA; Chen YH; Liang SS
Oncol Rep; 2021 Feb; 45(2):786. PubMed ID: 33416180
[TBL] [Abstract][Full Text] [Related]
44. [Corrigendum] Cyclophilin D modulates cell death transition from early apoptosis to programmed necrosis induced by honokiol.
Tian W; Xu D; Han W; He H; Cai H; Chen H; Zhou M; Chen J; Deng YC
Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33955504
[TBL] [Abstract][Full Text] [Related]
45. [Corrigendum] A potential therapeutic effect of CYP2C8 overexpression on anti‑TNF‑α activity.
Liu W; Wang B; Ding H; Wang DW; Zeng H
Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37477120
[TBL] [Abstract][Full Text] [Related]
46. [Corrigendum] The effect of NFATc1 on vascular generation and the possible underlying mechanism in epithelial ovarian carcinoma.
Li L; Yu J; Duan Z; Dang HX
Int J Oncol; 2020 Dec; 57(6):1381. PubMed ID: 33173961
[TBL] [Abstract][Full Text] [Related]
47. [Corrigendum] Celecoxib inhibits the epithelial‑to‑mesenchymal transition in bladder cancer via the miRNA‑145/TGFBR2/Smad3 axis.
Liu X; Wu Y; Zhou Z; Huang M; Deng W; Wang Y; Zhou X; Chen L; Li Y; Zeng T; Wang G; Fu B
Int J Mol Med; 2023 Aug; 52(2):. PubMed ID: 37326106
[TBL] [Abstract][Full Text] [Related]
48. [Corrigendum] A simplified 3D liver microsphere tissue culture model for hepatic cell signaling and drug-induced hepatotoxicity studies.
Zhu Y; Shi Q; Peng Q; Gao Y; Yang T; Cheng Y; Wang H; Luo Y; Huang A; He TC; Fan J
Int J Mol Med; 2023 Apr; 51(4):. PubMed ID: 36896773
[TBL] [Abstract][Full Text] [Related]
49. [Corrigendum] Mutation of TGF‑β receptor II facilitates human bladder cancer progression through altered TGF‑β1 signaling pathway.
Bian J; Li B; Zeng X; Hu H; Hong Y; Ouyang H; Zhang X; Wang Z; Zhu H; Lei P; Huang B; Shen G
Int J Oncol; 2021 Feb; 58(2):280. PubMed ID: 33491751
[TBL] [Abstract][Full Text] [Related]
50. [Corrigendum] Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer.
Lin J; Chen Z; Li Z; Nong D; Li X; Huang G; Hao N; Liang J; Li W
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35674160
[TBL] [Abstract][Full Text] [Related]
51. [Corrigendum] Carvacrol may alleviate vascular inflammation in diabetic db/db mice.
Zhao W; Deng C; Han Q; Xu H; Chen Y
Int J Mol Med; 2023 Oct; 52(4):. PubMed ID: 37594124
[TBL] [Abstract][Full Text] [Related]
52. [Corrigendum] Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.
Zhang W; Zhou K; Zhang X; Wu C; Deng D; Yao Z
Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37326099
[TBL] [Abstract][Full Text] [Related]
53. [Corrigendum] Deoxypodophyllotoxin inhibits cell viability and invasion by blocking the PI3K/Akt signaling pathway in human glioblastoma cells.
Wang W; Gao W; Zhang L; Zhang D; Zhao Z; Bao Y
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36660948
[TBL] [Abstract][Full Text] [Related]
54. [Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression.
Cai C; He H; Duan X; Wu W; Mai Z; Zhang T; Fan J; Deng T; Zhong W; Liu Y; Zhong W; Zeng G
Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36825583
[TBL] [Abstract][Full Text] [Related]
55. [Corrigendum] Epigallocatechin‑3‑gallate inhibits nicotine‑induced migration and invasion by the suppression of angiogenesis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells.
Shi J; Liu F; Zhang W; Liu X; Lin B; Tang X
Oncol Rep; 2023 Oct; 50(4):. PubMed ID: 37594121
[TBL] [Abstract][Full Text] [Related]
56. [Corrigendum] Epithelial mesenchymal transition induced by the CXCL9/CXCR3 axis through AKT activation promotes invasion and metastasis in tongue squamous cell carcinoma.
Li Z; Liu J; Li L; Shao S; Wu J; Bian L; He Y
Oncol Rep; 2021 Feb; 45(2):791-792. PubMed ID: 33416176
[TBL] [Abstract][Full Text] [Related]
57. [Corrigendum] Bax inhibitor‑1 suppresses early brain injury following experimental subarachnoid hemorrhage in rats.
Liu J; Zhou S; Zhang Y; Li X; Qian X; Tao W; Jin L; Zhao J
Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38426556
[TBL] [Abstract][Full Text] [Related]
58. [Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in early‑stage cervical cancer.
Ouyang F; Liu J; Xia M; Lin C; Wu X; Ye L; Song L; Li J; Wang J; Guo P; He M
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33882645
[TBL] [Abstract][Full Text] [Related]
59. [Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
Ji J; Shen I; Li Y; Liu Y; Shang Z; Niu Y
Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37477123
[TBL] [Abstract][Full Text] [Related]
60. [Corrigendum] Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells.
Yang L; Zheng S; Liu Q; Liu T; Zhang Q; Han X; Tuerxun A; Lu X
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 34981822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
